136 related articles for article (PubMed ID: 16236621)
21. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure.
Zenhäusern R; Tobler A; Leoncini L; Hess OM; Ferrari P
Ann Hematol; 2000 Sep; 79(9):523-6. PubMed ID: 11043425
[TBL] [Abstract][Full Text] [Related]
22. Diffuse alveolar hemorrhage following autologous bone marrow infusion.
Corso S; Vukelja SJ; Wiener D; Baker WJ
Bone Marrow Transplant; 1993 Sep; 12(3):301-3. PubMed ID: 8241990
[TBL] [Abstract][Full Text] [Related]
23. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S
Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079
[TBL] [Abstract][Full Text] [Related]
24. Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide.
Abrahamsen JF; Rusten L; Bakken AM; Bruserud Ø
Transfusion; 2004 May; 44(5):785-9. PubMed ID: 15104663
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
[TBL] [Abstract][Full Text] [Related]
26. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
Morris C; de Wreede L; Scholten M; Brand R; van Biezen A; Sureda A; Dickmeiss E; Trneny M; Apperley J; Chiusolo P; van Imhoff GW; Lenhoff S; Martinelli G; Hentrich M; Pabst T; Onida F; Quinn M; Kroger N; de Witte T; Ruutu T;
Transfusion; 2014 Oct; 54(10):2514-22. PubMed ID: 24964911
[TBL] [Abstract][Full Text] [Related]
27. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis.
Benekli M; Anderson B; Wentling D; Bernstein S; Czuczman M; McCarthy P
Bone Marrow Transplant; 2000 Jun; 25(12):1299-301. PubMed ID: 10871736
[TBL] [Abstract][Full Text] [Related]
28. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing.
Calmels B; Houzé P; Hengesse JC; Ducrot T; Malenfant C; Chabannon C
Bone Marrow Transplant; 2003 May; 31(9):823-8. PubMed ID: 12732892
[TBL] [Abstract][Full Text] [Related]
29. Infusion technique of hematopoietic progenitor cells and related adverse events (CME).
Mulay SB; Greiner CW; Mohr A; Bryant SC; Lingineni RK; Padley D; Hogan WJ; Gastineau DA; Jacob EK
Transfusion; 2014 Aug; 54(8):1997-2003; quiz 1996. PubMed ID: 24697759
[TBL] [Abstract][Full Text] [Related]
30. [Hemolytic uremic syndrome-like episode following nonmyeloablative hematopoietic stem cell transplantation in a patient with chronic myeloid leukemia].
Takahashi N; Miura I; Kume M; Kawabata Y; Hirokawa M; Sawada K
Rinsho Ketsueki; 2003 Jun; 44(6):391-5. PubMed ID: 12884818
[TBL] [Abstract][Full Text] [Related]
31. Adverse events of cryopreserved hematopoietic stem cell infusions in adults: a single-center observational study.
Otrock ZK; Sempek DS; Carey S; Grossman BJ
Transfusion; 2017 Jun; 57(6):1522-1526. PubMed ID: 28301051
[TBL] [Abstract][Full Text] [Related]
32. A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch.
Rowley SD; Feng Z; Chen L; Holmberg L; Heimfeld S; MacLeod B; Bensinger WI
Bone Marrow Transplant; 2003 Jun; 31(11):1043-51. PubMed ID: 12774058
[TBL] [Abstract][Full Text] [Related]
33. Hematologic, immunologic reconstitution, and outcome of 342 autologous peripheral blood stem cell transplantations after cryopreservation in a -80°C mechanical freezer and preserved less than 6 months.
Calvet L; Cabrespine A; Boiret-Dupré N; Merlin E; Paillard C; Berger M; Bay JO; Tournilhac O; Halle P
Transfusion; 2013 Mar; 53(3):570-8. PubMed ID: 22804351
[TBL] [Abstract][Full Text] [Related]
34. Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients.
Martino M; Morabito F; Messina G; Irrera G; Pucci G; Iacopino P
Haematologica; 1996; 81(1):59-61. PubMed ID: 8900855
[TBL] [Abstract][Full Text] [Related]
35. Prevention of dimethylsulfoxide-related nausea and vomiting by prophylactic administration of ondansetron for patients receiving autologous cryopreserved peripheral blood stem cells.
Eisenberg S; Wickline M; Linenberger M; Gooley T; Holmberg L
Oncol Nurs Forum; 2013 May; 40(3):285-92. PubMed ID: 23615140
[TBL] [Abstract][Full Text] [Related]
36. A faster reconstitution of hematopoiesis after autologous transplantation of hematopoietic cells cryopreserved in 7.5% dimethyl sulfoxide if compared to 10% dimethyl sulfoxide containing medium.
Mitrus I; Smagur A; Giebel S; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Sadus-Wojciechowska M; Tukiendorf A; Holowiecki J
Cryobiology; 2013 Dec; 67(3):327-31. PubMed ID: 24125911
[TBL] [Abstract][Full Text] [Related]
37. The impact of preapheresis white blood cell count on autologous peripheral blood stem cell collection efficiency and HSC infusion side effect rate.
Sakashita AM; Kondo AT; Yokoyama APH; Lira SMC; Bub CB; Souza AM; Cipolletta ANF; Alvarez KC; Hamerschlak N; Kutner JM; Chiattone CS
J Clin Apher; 2018 Jun; 33(3):331-341. PubMed ID: 29350425
[TBL] [Abstract][Full Text] [Related]
38. Precipitation of ventricular bigeminy by DMSO during autologous haematopoietic stem cell transplantation.
Hoskote SS; Reddy DR; Onigkeit JA
Transfus Med; 2015 Apr; 25(2):118-21. PubMed ID: 25808255
[No Abstract] [Full Text] [Related]
39. Autoimmune thrombocytopenia with clonal expansion of CD8-positive T cells after autologous peripheral blood stem cell transplantation for diffuse large B-cell lymphoma.
Isobe T; Tanimoto TE; Nakaji G; Miyamoto T; Yamasaki S; Takase K; Numata A; Fukuda T; Nagafuji K; Inaba S; Harada M
Bone Marrow Transplant; 2005 Feb; 35(3):315-6. PubMed ID: 15568035
[No Abstract] [Full Text] [Related]
40. Plasma concentrations and pharmacokinetics of dimethylsulfoxide and its metabolites in patients undergoing peripheral-blood stem-cell transplants.
Egorin MJ; Rosen DM; Sridhara R; Sensenbrenner L; Cottler-Fox M
J Clin Oncol; 1998 Feb; 16(2):610-5. PubMed ID: 9469349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
